Patients with IPF and emphysema who received antifibrotic agents had similar outcomes to patients with IPF alone.
BACKGROUND: PYGM (muscle glycogen phosphorylase), the rate-limiting enzyme in glycogenolysis, plays an indispensable role in maintaining cardiac energy metabolism. However, the role of PYGM in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback